CDEK by Data4ThePeople

Sign in Sign up

← All drugs Report issue

hrs-7535

Small moleculeexperimental

Clinical trial activity

19 trials · 2 clinical orgs · 0 marketing orgs

Phase 1

10

Phase 2

10

Phase 3

3

Phase 4

0

Earliest trial started May 1, 2022 (NCT05347758)

Timeline

2020s

Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Jan 1, 2023
Earliest Phase 2 Sponsor(trial)
Jan 1, 2024
Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Glucagon-like peptide 1 receptorAGONIST
GLP1R agonist
- Glucagon-like peptide 1 receptor (GLP1R) ↗

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT ID	Phase	Start date	Sponsor(s)
NCT07269756	Phase 1	Dec 31, 2025	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT07294898	Phase 1	Dec 11, 2025	Kailera
NCT06961643	Phase 1	Jun 5, 2025	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06904105	Phase 3	Apr 9, 2025	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06820099	Phase 2	Mar 31, 2025	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06819488	Phase 1	Feb 27, 2025	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06727838	Phase 1	Dec 31, 2024	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06671821	Phase 2	Nov 30, 2024	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06672172	Phase 3	Nov 30, 2024	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06621316	Phase 1/Phase 2 (Phase 2)	Oct 20, 2024	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06589765	Phase 3	Sep 18, 2024	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06495931	Phase 1	Jul 31, 2024	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06415214	Phase 2	Jun 30, 2024	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06393348	Phase 2	Jun 30, 2024	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06422039	Phase 1	May 15, 2024	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06250946	Phase 2	Feb 29, 2024	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06132204	Phase 1	Nov 30, 2023	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT05759897	Phase 2	Feb 28, 2023	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT05347758	Phase 1	May 1, 2022	Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Showing 19 of 19 trials

Page 1 / 1

Organizations

Research & Development (2)

Organization	Org type	Trials	As lead sponsor	Phases	Earliest year
Suzhou Suncadia Biopharmaceuticals Co., Ltd.	For profit	18	18	3	2022
Kailera	For profit	1	1	1	2025

2 organizations

Page 1 / 1